A 12 Month, Multi-center, Open-label, Randomized, Controlled Study to Evaluate Efficacy/Safety and Evolution of Renal Function of Everolimus in Co-exposure With Tacrolimus in de Novo Liver Transplant Recipients.
Phase of Trial: Phase IV
Latest Information Update: 24 May 2017
At a glance
- Drugs Everolimus (Primary) ; Tacrolimus
- Indications Liver transplant rejection
- Focus Adverse reactions
- Acronyms HEPHAISTOS
- Sponsors Novartis
- 05 Aug 2016 Planned End Date changed from 1 May 2017 to 1 Aug 2017.
- 02 Aug 2016 Planned primary completion date changed from 1 May 2017 to 1 Aug 2017.
- 16 Sep 2015 According to an abstract presented at the 17th Congress of the European Society for Organ Transplantation, 156 patients have been recruited till date.